Wellcome Sanger Institute

The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.

Telephone:	+44 (0)1223 834 244
Address:	Wellcome Genome Campus, Hinxton
Postcode:	CB10 1SA
Country:	United Kingdom
Website:	http://www.sanger.ac.uk
Membership type:	Corporate 51+ (£1,000+VAT pa)

Profile
Products & services
News
Events
Jobs

Its success is founded on the expertise and knowledge of its people and the Institute seeks to share its discoveries and techniques with the next generation of genomics scientists and researchers worldwide.

Largest study of CRISPR-Cas9 mutations creates prediction tool for gene editing

The largest study of CRISPR action to date has developed a method to predict the exact mutations CRISPR-Cas9 gene editing can introduce to a cell.

29 November 2018Read in full

Mapping individual maternal and fetal cells within the decidua

Human cell atlas study reveals how the maternal immune system is modified early in pregnancy

Cell map of healthy pregnancy could also help understand miscarriages or preeclampsia

14 November 2018Read in full

Study compared the genomes of 81 worm species

Largest parasitic worm genetic study hatches novel treatment possibilities

The largest genomic study of parasitic worms to date has identified hundreds of thousands of new genes and predicted many new potential drug targets and drugs.

8 November 2018Read in full

Genetic code of 66,000 UK species to be sequenced

The genetic codes of 66,000 species in the UK are planned to be sequenced by the Wellcome Sanger Institute and its collaborators as part of a global effort to sequence the genomes of all 1.5 million known species of animals, plants, protozoa and fungi on Earth.

1 November 2018Read in full

Researchers studied gene activity from 250,000 cells

Study reveals how gene activity shapes immunity across species

By sequencing genes from over a quarter of a million cells across six mammalian species, researchers at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute and collaborators, have shown how genes in the immune response have varied activity between cells and species.

29 October 2018Read in full

Cancer Gene Census summarises over 700 genes

Largest census of cancer genes will help scientists understand causes and find drug targets

Researchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involved in human cancer, the “Cancer Gene Census”.

25 October 2018Read in full

Mutant cells colonise our tissues over our lifetime

By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists at the Wellcome Sanger Institute, MRC Cancer Unit, University of Cambridge and their collaborators uncovered a hidden world of mutations and evolution in our tissues as we age.

19 October 2018Read in full

Genetics allows personalised disease predictions for chronic blood cancers

Scientists have developed a successful method to make truly personalised predictions of future disease outcomes for patients with certain types of chronic blood cancers.

12 October 2018Read in full

Newly sequenced mouse genomes unearth unknown genes

Scientists at EMBL's European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute have discovered significant diversity in the genomes of 16 laboratory strains of mouse, potentially impacting future research in genetics, drug development and beyond.

9 October 2018Read in full